Literature DB >> 20578178

Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment?

Sara N Red1, Elisabeth C Kassan, Randi M Williams, Sofiya Penek, John Lynch, Chiledum Ahaghotu, Kathryn L Taylor.   

Abstract

BACKGROUND: Evidence suggests that colorectal cancer (CRC) screening reduces disease-specific mortality, whereas the utility of prostate cancer screening remains uncertain. However, adherence rates for prostate cancer screening and CRC screening are very similar, with population-based studies showing that approximately 50% of eligible US men are adherent to both tests. Among men scheduled to participate in a free prostate cancer screening program, the authors assessed the rates and correlates of CRC screening to determine the utility of this setting for addressing CRC screening nonadherence.
METHODS: Participants (N = 331) were 50 to 70 years old with no history of prostate cancer or CRC. Men registered for free prostate cancer screening and completed a telephone interview 1 to 2 weeks before undergoing prostate cancer screening.
RESULTS: One half of the participants who underwent free prostate cancer screening were eligible for but nonadherent to CRC screening. Importantly, 76% of the men who were nonadherent to CRC screening had a regular physician and/or health insurance, suggesting that CRC screening adherence was feasible in this group. Furthermore, multivariate analyses indicated that the only significant correlates of CRC screening adherence were having a regular physician, health insurance, and a history of prostate cancer screening.
CONCLUSIONS: Free prostate cancer screening programs may provide a teachable moment to increase CRC screening among men who may not have the usual systemic barriers to CRC screening, at a time when they may be very receptive to cancer screening messages. In the United States, a large number of men participate in annual free prostate cancer screening programs and represent an easily accessible and untapped group that can benefit from interventions to increase CRC screening rates.
© 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20578178      PMCID: PMC3639486          DOI: 10.1002/cncr.25229

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  46 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

Review 2.  Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

3.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

4.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

5.  Use of colorectal cancer tests--United States, 2002, 2004, and 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-03-14       Impact factor: 17.586

6.  A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.

Authors:  Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

7.  Influence of family history and preventive health behaviors on colorectal cancer screening in African Americans.

Authors:  Kathleen A Griffith; Deborah B McGuire; Renee Royak-Schaler; Keith O Plowden; Eileen K Steinberger
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

8.  Improving colorectal cancer screening among the medically underserved: a pilot study within a federally qualified health center.

Authors:  Kishore Khankari; Mickey Eder; Chandra Y Osborn; Gregory Makoul; Marla Clayman; Silvia Skripkauskas; Linda Diamond-Shapiro; Dan Makundan; Michael S Wolf
Journal:  J Gen Intern Med       Date:  2007-07-26       Impact factor: 5.128

9.  Factors associated with racial/ethnic differences in colorectal cancer screening.

Authors:  Navkiran K Shokar; Carol A Carlson; Susan C Weller
Journal:  J Am Board Fam Med       Date:  2008 Sep-Oct       Impact factor: 2.657

10.  Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.

Authors:  Melissa M Farmer; Roshan Bastani; Lorna Kwan; Michael Belman; Patricia A Ganz
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

View more
  4 in total

1.  Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program.

Authors:  Michael J Hall; Karen Ruth; Veda N Giri
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

2.  Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancer.

Authors:  Yu-Ning Wong; Elliot J Coups
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

3.  Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study.

Authors:  Marianne F Weber; Michelle Cunich; David P Smith; Glenn Salkeld; Freddy Sitas; Dianne O'Connell
Journal:  BMC Public Health       Date:  2013-05-03       Impact factor: 3.295

4.  Who are the under- and never-screened for cancer in Ontario: a qualitative investigation.

Authors:  Dionne Gesink; Alanna Mihic; Joan Antal; Brooke Filsinger; C Sarai Racey; Daniel Felipe Perez; Todd Norwood; Farah Ahmad; Nancy Kreiger; Paul Ritvo
Journal:  BMC Public Health       Date:  2014-05-23       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.